GlassScriptPhysician profile
Matthew Schuch
NPI 1457857138
$38,350.55
in general payments reported to CMS, 2019-2025
21 companies · $808 in 2025
The $808 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,379 · 2020: $3,755 · 2021: $5,288 · 2022: $15K · 2023: $1,353 · 2024: $4,718 · 2025: $808.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,666 · Travel and Lodging: $3,214.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,666.16 |
| Travel and Lodging | $3,213.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pinnacle, INC | $25,883.13 | 2019-2022 | |
| Stryker Corporation | $6,723.58 | 2019-2025 | Pro, T2 Alpha, Variax |
| Zimmer Biomet Holdings, INC. | $1,432.90 | 2019-2025 | Persona, A.L.P.S., Synovasure Alpha Defensin |
| Arthrex, INC. | $950.55 | 2024 | |
| Avanos Medical | $568.45 | 2019-2023 | On-Q* Pump and Accessories |
| Globus Medical, INC. | $469.55 | 2025 | Anthem, Autobahn |
| Depuy Synthes Sales INC. | $339.28 | 2019-2024 | Na |
| Linvatec Corporation | $303.03 | 2023-2024 | Biobrace 23mm |
| Goode Surgical INC | $291.72 | 2023-2025 | |
| Innovation Technologies INC | $290.82 | 2022 | |
| Zak Ortho | $202.75 | 2024-2025 | |
| Osteocentric Technologies, INC. | $137.66 | 2023 | Osteocentric 4.0 X 130mm Locking Bone Screw Fastener St |
| Paragon 28, INC. | $127.03 | 2022-2025 | R3flex, Phantom Fibula Nail |
| Si-Bone, INC. | $125.00 | 2020 | |
| Novo Nordisk INC | $124.74 | 2023 | Wegovy |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $119.47 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $118.42 | 2022 | |
| Kci USA, INC. | $94.50 | 2022 | |
| Tenex Health INC. | $18.08 | 2021 | |
| Endo Pharmaceuticals INC. | $15.36 | 2021 | |
| Bioventus LLC | $14.53 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Schuch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.